In the last two decades, non-alcoholic fatty liver disease (NAFLD), has transitioned from a non-existent entity to become one of the leading etiologies of chronic liver disease in the world.
Liver transplantation in patients with non-alcoholic steatohepatitis and alcohol-related liver disease: the dust is yet to settle
Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation
Pre-transplant portal vein thrombosis in non-alcoholic fatty liver disease patients—pathogenesis, risk factors, and implications on management
Peri-transplant renal dysfunction in patients with non-alcoholic steatohepatitis undergoing liver transplantation
Multimodal multidisciplinary management of alcohol use disorder in liver transplant candidates and recipients
The series “Liver Transplantation in NASH and ALD” was commissioned by the editorial office, Translational Gastroenterology and Hepatology without any sponsorship or funding. Sanjaya Satapathy, David E. Bernstein and Nitzan C. Roth are serving as the unpaid Guest Editors for the series.